David Whitacre

Dr. Whitacre was recruited by VLP Biotech in 2007, from the UCSD Moores Cancer Center in La Jolla, California, where he developed viral-vectored cancer immune therapeutics. Drawing on this experience he quickly became an integral part of the VLP team, providing expertise in chimeric protein engineering and biochemistry in a set of multifaceted collaborations. His work has been pivotal in the exploitation of the features of the VLP vaccine platform, leading, thus far, to multiple publications and patents and several millions of dollars in grant and industry funding. In addition to his role at VLP Biotech, Dr. Whitacre holds an appointment as an Associate Professor at the Vaccine Research Institute of San Diego.